Scribosp. z o.o.

Activities of insurance agents and brokers

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2015-04-01
Share capital
5,000.00 PLN
Registered address
ul. Marii I Bolesława Wysłouchów 4/45, 30-611 Kraków, Poland

Financials

Revenue history (in k)

Filing timeliness

No financial statement for 2024 – the filing deadline has passed. 6 of 6 financial statements were filed late (the longest delay 744 days for 2021).

  • 2024not filed
  • 202330/10/2024
  • 202230/07/2024
  • 202128/07/2024
  • 202005/01/2023
  • 201909/06/2022
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, region and across Poland in 2023.

Results vs industry

Revenue
This companyUSD 97.26kMedianUSD 105.79kAverageUSD 1.26m
Net profit
This companyUSD -272.10MedianUSD 5.79kAverageUSD 141.94k
Operating costs
This companyUSD 97.53kMedianUSD 86.35kAverageUSD 1.04m
Assets
This companyUSD 1.12kMedianUSD 52.17kAverageUSD 1.10m

Authorized Representatives

Monika Maria Doerre – Vice President of the Management Board
Maria Kurowska Pluta – President of the Management Board

Manner of representation

Each of the members of the management board, acting independently, is authorized to make declarations of will concerning the Company’s property and non-property rights and obligations and to sign all documents on behalf of the Company.

Ownership

OwnerSharesShare valueStake
Monika Maria Doerreage 41
18$486.2236%
Maria Elżbieta Kurowska Plutaage 69
18$486.2236%
Edyta Wdaniecage 48
14$378.1728%

Beneficial owners

Person

Debt

No entries in the National Debtors Register (KRZ).

Public aid

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$828
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$809

Regulatory authorisations

AuthorityTypeStatus
Insurance broker Active

FAQ

Last updated: 2026-04-11